The updated data, from the phase 3 NATALEE trial, were shared Friday at the 2023 San Antonio Breast Cancer Symposium (SABCS). Novartis and the FDA ...
News
- SABCS: As Lilly showdown nears, Novartis gives another look at Kisqali data in early breast cancer
- MBrace Therapeutics Presents Preclinical Data Demonstrating Potential of Novel Antibody ...
... San Antonio Breast Cancer Symposium taking place December 5-9, 2023, in ... Biotech Stock Roundup: EXEL Partners RCUS for Study, PHVS & EYPT Gain ...
- Some Breast Cancer Patients May Be Able to Forgo Adjuvant Regional Nodal Irradiation
... San Antonio Breast Cancer Symposium. With this phase 3 trial ... Disclosures: Some study authors declared affiliations with biotech, pharmaceutical, and ...
- Ryvu Therapeutics Presents Data on RVU120 at the San Antonio Breast Cancer Symposium 2023
... San Antonio Breast Cancer Symposium (SABCS) 2023 being held on December ... Biotech Stock Roundup: EXEL Partners RCUS for Study, PHVS & EYPT Gain ...
- Oncolytics Biotech® and SOLTI Present Positive Translational Data at SABCS | BioSpace
... San Antonio Breast Cancer Symposium (SABCS). Oncolytics Biotech Logo. "Translational data presented from the AWARE-1 study at SABCS showed that ...